Tenax Therapeutics (TENX) Shares Outstanding (2010 - 2026)
Tenax Therapeutics (TENX) posted quarterly Shares Outstanding (Entity) of $50.9 million for Q2 2026, up 28.55% year-over-year from $39.6 million in Q2 2025, and up 12.48% on a QoQ basis from $45.2 million in Q1 2026.
Tenax Therapeutics (TENX) Shares Outstanding (2010 - 2026) Analysis & Trends
Tenax Therapeutics has reported Shares Outstanding (Entity) for 17 years, with the latest figure at $50.9 million in Q2 2026.
- Shares Outstanding (Entity) for Q2 2026 came in at $50.9 million, up 28.55% year-over-year; the trailing twelve-month figure through Jun 2026 was $50.9 million (up 28.55% YoY), and the FY2025 annual result was $39.2 million, up 156.8% from the prior year.
- Shares Outstanding (Entity) climbed to $50.9 million in Q2 2026, from $45.2 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $50.9 million in Q2 2026 and troughed at $15754.0 in Q1 2022.
- A 5-year average of $16.2 million and a median of $1.6 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The widest annual swing landed in 2022, when Shares Outstanding (Entity) advanced 18.96%; it then soared 6994.39% in 2024.
- A 5-year view of Shares Outstanding (Entity) shows it stood at $18391.0 in 2022, then surged by 1250.92% to $248447.0 in 2023, then surged by 6046.87% to $15.3 million in 2024, then jumped by 156.8% to $39.2 million in 2025, then grew by 29.71% to $50.9 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $50.9 million in Q2 2026, $45.2 million in Q1 2026, and $39.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | 45.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.87 Mn |
| Mar 31, 2026 | 45.23 Mn |
| Dec 31, 2025 | 39.22 Mn |
| Sep 30, 2025 | 39.74 Mn |
| Jun 30, 2025 | 39.57 Mn |
| Mar 31, 2025 | 36.58 Mn |
| Dec 31, 2024 | 15.27 Mn |
| Sep 30, 2024 | 21.16 Mn |
| Jun 30, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 248,447.00 |
| Sep 30, 2023 | 298,280.00 |
| Jun 30, 2023 | 276,454.00 |
| Mar 31, 2023 | 116,259.00 |
| Dec 31, 2022 | 18,391.00 |
| Sep 30, 2022 | 16,456.00 |
| Jun 30, 2022 | 15,754.00 |
| Mar 31, 2022 | 15,754.00 |
| Dec 31, 2021 | 12,861.00 |
| Sep 30, 2021 | 15,751.00 |